-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-02-05
3020-OL:HK:HK-X DBMSCIUSA (HKD)
COMMON STOCK | Other |
Last Closing
USD 1385Change
0.00 (0.00)%Market Cap
N/AVolume
225.00Analyst Target
N/AN/A
Verdict
Values as of: 2025-02-05
COMMON STOCK | Other |
Last Closing
USD 1385Change
0.00 (0.00)%Market Cap
N/AVolume
225.00Analyst Target
N/AN/A
Verdict
There is no Profile data available for 3020-OL.HK.
Currency: HKD
Country : Hong Kong
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
1318:HK | Mao Geping Cosmetics Co Ltd |
-2.75 (-3.74%) |
USD 28.92B |
0325:HK | Bloks Group Ltd |
-4.25 (-4.25%) |
USD 22.55B |
1863:HK | China Longevity Group Company .. |
N/A |
USD 1.17B |
8355:HK | I-CONTROL |
N/A |
USD 0.39B |
8343:HK | HongGuang Lighting Holdings Co.. |
-0.02 (-2.99%) |
USD 0.31B |
0648:HK | CHINA RENJ |
N/A |
USD 0.12B |
0400-OL:HK | COGOBUY |
N/A |
N/A |
0240-OL:HK | BUILD KING HOLD |
+0.01 (+1.06%) |
N/A |
0406-OL:HK | YAU LEE HOLD |
N/A |
N/A |
0243-OL:HK | QPL INT'L |
N/A |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
DXZ:CA | Dynamic Active U.S. Mid-C.. | 11.35 % | 0.87 % |
+0.02 (+0.66%) |
CAD 0.03B |
IHF | iShares U.S. Healthcare P.. | 10.39 % | 0.43 % |
-0.02 (0.66%) |
N/A |
TETF | 6.19 % | 0.64 % |
N/A |
N/A | |
BGU:CA | Bristol Gate Concentrated.. | 5.18 % | 0.85 % |
+0.57 (+0.66%) |
CAD 0.13B |
IAI | iShares U.S. Broker-Deale.. | 4.32 % | 0.42 % |
+1.27 (+0.66%) |
N/A |
HDIV | 2.83 % | 0.00 % |
N/A |
N/A | |
PFUT | Putnam Sustainable Future.. | 1.73 % | 0.00 % |
+0.18 (+0.66%) |
USD 0.32B |
RYH | 1.72 % | 0.40 % |
N/A |
N/A | |
DSTL | Distillate US Fundamental.. | 1.71 % | 0.00 % |
+0.40 (+0.66%) |
USD 2.01B |
HONR | 1.20 % | 0.65 % |
N/A |
N/A | |
IFSW:LSE | iShares Edge MSCI World M.. | 1.11 % | 0.00 % |
+0.01 (+0.66%) |
N/A |
FSWD:LSE | iShares Edge MSCI World M.. | 1.11 % | 0.00 % |
-1.75 (0.66%) |
N/A |
IS07:F | iShares IV Public Limited.. | 1.11 % | 0.00 % |
N/A |
N/A |
IS07:XETRA | iShares Edge MSCI World M.. | 1.11 % | 0.00 % |
N/A |
USD 0.01B |
VVL:CA | Vanguard Global Value Fac.. | 0.63 % | 0.40 % |
+0.22 (+0.66%) |
N/A |
SMD | 0.45 % | 0.10 % |
N/A |
N/A | |
ESGL | ESGL Holdings Limited Ord.. | 0.00 % | 0.40 % |
N/A |
USD 0.05B |
JKH | iShares Morningstar Mid-C.. | 0.00 % | 0.30 % |
N/A |
N/A |
DRFU:CA | Desjardins RI USA Multifa.. | 0.00 % | 0.57 % |
N/A |
CAD 5.97M |
SPVM | Invesco S&P 500 Value wit.. | 0.00 % | 0.39 % |
+0.36 (+0.66%) |
USD 0.09B |
RYF | 0.00 % | 0.40 % |
N/A |
N/A | |
WBIF | WBI BullBear Value 3000 E.. | 0.00 % | 1.05 % |
+0.19 (+0.66%) |
N/A |
XXM:CA | 0.00 % | 0.68 % |
N/A |
N/A | |
IBCZ:F | iShares IV Public Limited.. | 0.00 % | 0.00 % |
N/A |
N/A |
IMCG | iShares Morningstar Mid-C.. | 0.00 % | 0.00 % |
+0.80 (+0.66%) |
N/A |
Market Performance vs. Industry/Classification (Other) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 1.91% | 68% | D+ | 67% | D+ | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 1.91% | 68% | D+ | 67% | D+ | ||
Trailing 12 Months | |||||||
Capital Gain | 22.67% | 71% | C- | 72% | C | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 22.67% | 69% | C- | 70% | C- | ||
Trailing 5 Years | |||||||
Capital Gain | 97.43% | 81% | B- | 92% | A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 97.43% | 81% | B- | 90% | A- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 17.32% | 76% | C+ | 76% | C+ | ||
Dividend Return | 17.32% | 75% | C | 75% | C | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 20.15% | 74% | C | 74% | C | ||
Risk Adjusted Return | 85.95% | 98% | N/A | 97% | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
There is nothing we particularly dislike